Management team

Eric Alsac is the Vice President, Consumer Healthcare at Norgine.

Eric joined Norgine in 2014 as a Global Commercial Intelligence Manager. Since then, he has undertaken a variety of roles within the Commercial Function in the United Kingdom and most recently, in The Netherlands as General Manager.

Prior to Norgine, Eric worked as a Business Analyst at Ipsen in France and Walgreens Boots Alliance in the United Kingdom.

Eric holds a Doctor of Pharmacy degree from the University of Lille and a Masters in Marketing from HEC Paris.

Alan is responsible for all Corporate Development activity and is based in the US, where he is focused on deepening Norgine’s North American relationships.
He has over 30 years’ experience in the pharma industry, having held senior Corporate Development roles at Lupin, AMAG, Purdue Pharma and Shire.
Alan started his career in the pharma industry as a scientist and he holds a BSc in Clinical Microbiology and an MA in Biology with a concentration in Molecular Biology and Genetics from West Chester University of Pennsylvania. He is also an MBA graduate, from Cornell University’s Johnson Graduate School of Management.

Philippe Caroff is the Chief Manufacturing Officer at Norgine.

Philippe joined Norgine in 2013 as Director for External Network, looking after all outsourced manufacturing activities and since mid-2015 has also taken responsibilities for Supply Chain & Distribution activities.

Prior to this, Philippe worked for a number of companies including Ipsen, Cap Gemini, Seagram and BP, in various positions in Manufacturing, Supply chain, Purchasing activities and also in Research & Development, with more than 15 years in the Pharmaceutical industry. Philippe graduated from Ecole des Mines de St Etienne in General Engineering.

Dr David Gillen is the Chief Medical Officer at Norgine.

David qualified in Medicine, Physiology and Clinical Pharmacology from St. Mary’s Hospital in 1992 and joined Pfizer in 1999, where he spent 12 years in a number of local and global roles, including UK Medical Director and VP of Medical Affairs for Pfizer’s Primary Care Business Unit.

Subsequently David worked in a number of senior roles at Celgene, Gilead Sciences, Vertex Therapeutics and Menarini, working across Specialist Care and Rare Diseases, before joining Norgine in 2022.

Raj Daruvala is the Vice President, Transformation Management at Norgine. In this role, he is responsible for delivering Norgine’s Transformation Programme, aptly titled NewChapter. He joined Norgine in June 2018 as Head of Financial Planning and Reporting.

Raj has over 20 years’ experience in the pharmaceutical industry having worked for Bristol Myers Squib in UK and the US holding a number of roles in Finance supporting Commercial, R&D, Manufacturing and Mergers & Acquisitions.

Raj has an MBA from Indiana University, USA and is also a Certified Public Accountant.

Marc Gorham is the Vice President, IT at Norgine.

Marc joined Norgine in 2005 as Business Analyst to consolidate our ERP systems. Since then he has undertaken a variety of roles within the IT function, that he now leads, and has been instrumental in its evolution.

Prior to Norgine, Marc delivered technology initiatives as a consultant for PeopleSoft, JDEdwards and Catalyst Solutions across a variety of industry sectors.

His career started in healthcare during his 13 year tenure with Oxford Instruments.

Sheila Hopkins is the Chief Legal Officer at Norgine.

Prior to joining Norgine in 2006 Sheila worked for the law firm Latham & Watkins in London and New York and clerked for a Federal Court judge in the Second Circuit, New York.

Sheila holds a BA from Harvard College and a JD from the University of Pennsylvania Law School.

Michael Lange is Vice President, Global General Manager.

Michael joined Norgine in 2020 as General Manager for Germany. In his previous role at Amgen, he worked as Business Unit Director of Immunology and Inflammation in Germany.

Michael started his career as a Sales Representative for Hoechst in Germany and held a number of increasingly senior roles in several pharmaceutical companies including Sales, Marketing, Medical Affairs and Market Access.

Those companies include Aventis Pharma, AstraZeneca, Schering-Plough, Celgene and GlaxoSmithKline. He has spent most of his working life in Germany but has also spent 5 years in the United States and 3 years in the UK.

Wendy Logan is the Vice President, Business Unit Head for Launch Brands and Growth Brands at Norgine.

Wendy has more than 20 years in industry from big pharma to biotech start-ups. Throughout her career, she has gained deep leadership experience in country and global commercialisation functions, in Specialty Care, with a specific focus on building launch expertise.

Lesley Roche is the Chief Financial Officer at Norgine.

Prior to joining Norgine in July 2020, Lesley was the Group Financial Controller at De La Rue plc, supporting the group in a number of business disposals as well as leading the team through its finance transformation.

Prior to joining De La Rue in 2016, Lesley worked for many years in the Life Science sector, spending 12 years at Amersham/GE Healthcare and 11 years at Shire. During her career she has had roles across all areas of finance and whilst at Shire Lesley was responsible for the establishment of their global finance operations footprint and shared service centre strategy, as well as the integration of multiple acquisitions.

Bob Rogmans is the Chief Human Resources Officer at Norgine.

Prior to joining Norgine in April 2017, Bob was HR Director at Astellas Pharma Europe, supporting Medical and Development in EMEA as well as the Commercial Middle East and Africa Affiliate.

Bob has worked for more than 25 years in the field of Human Resources in various roles across different organisations such as TomTom, Accenture and Hewlett Packard. Bob holds a BA in Human Resources & Business Administration.